Related Experiment Video
Updated: Aug 11, 2026

09:48
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
Metastasizing Pleomorphic Adenoma: A Systematic Review and Pooled Case-Report Analysis
Stefan Janik1,2, Blazen Marijic1,3, Filip Tudor3
1Institute of Head and Neck Diseases, Evangelical Hospital, 1180 Vienna, Austria.
Cancers
|July 28, 2026
Summary
Metastasizing pleomorphic adenoma (MPA) is a rare salivary gland tumor with benign morphology but metastatic behavior. Surgical management may improve survival, but evidence is limited by case reports and data gaps.
Area of Science:
- Oncology
- Pathology
- Surgical Oncology
Background:
- Metastasizing pleomorphic adenoma (MPA) is a rare salivary gland tumor with benign morphology but metastatic potential.
- Existing evidence is largely based on case reports and small series, necessitating a comprehensive review of patient-level data.
Purpose of the Study:
- To systematically review and pool published patient data on MPA.
- To explore clinicopathologic features, metastatic patterns, treatment strategies, and survival outcomes.
- To identify areas for future research and improved management.
Main Methods:
- Systematic literature search of PubMed, Scopus, and Google Scholar up to August 2025.
- Pooled analysis of 122 published case-report patients with MPA (excluding malignant variants).
- Exploratory survival analyses using Kaplan-Meier and univariable Cox models due to limited death data.
Main Results:
- The majority of primary tumors arose in the parotid gland (75.4%).
- Common metastatic sites included bone/skeleton and lymph nodes/neck (35.0% each), followed by lung (25.8%).
- Surgery was associated with improved overall survival (log-rank p=0.008), though this finding is exploratory.
Conclusions:
- MPA is challenging to predict, with evidence limited by study design and data heterogeneity.
- Surgical management may be considered for selected MPA patients, but the survival association requires cautious interpretation due to potential biases.
- Multicenter registries, standardized reporting, and molecular characterization are crucial for advancing MPA understanding and treatment.

